Skip to main content
  • More from ADA
    • Diabetes
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care
  • Subscribe
  • Log in
  • My Cart
  • Follow ada on Twitter
  • RSS
  • Visit ada on Facebook
Diabetes Care

Advanced Search

Main menu

  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • Special Article Collections
    • ADA Standards of Medical Care
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • Special Article Collections
    • ADA Standards of Medical Care
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Journal Policies
    • Instructions for Authors
    • ADA Peer Review
  • More from ADA
    • Diabetes
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care

User menu

  • Subscribe
  • Log in
  • My Cart

Search

  • Advanced search
Diabetes Care
  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • Special Article Collections
    • ADA Standards of Medical Care
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • Special Article Collections
    • ADA Standards of Medical Care
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Journal Policies
    • Instructions for Authors
    • ADA Peer Review
Novel Communications in Diabetes

Acute Hyperglycemia and Spatial Working Memory in Adolescents With Type 1 Diabetes

  1. Jasna Šuput Omladič1,2,
  2. Anka Slana Ozimič3,
  3. Andrej Vovk4,
  4. Dušan Šuput4,
  5. Grega Repovš3,
  6. Klemen Dovc1,2,
  7. Nataša Bratina1,2,
  8. Magdalena Avbelj Stefanija1,2 and
  9. Tadej Battelino1,2⇑
  1. 1UMC-University Children’s Hospital Ljubljana, Ljubljana, Slovenia
  2. 2Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia
  3. 3Faculty of Arts, University of Ljubljana, Ljubljana, Slovenia
  4. 4Institute of Pathophysiology, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia
  1. Corresponding author: Tadej Battelino, tadej.battelino{at}mf.uni-lj.si
Diabetes Care 2020 Aug; 43(8): 1941-1944. https://doi.org/10.2337/dc20-0171
PreviousNext
  • Article
  • Figures & Tables
  • Suppl Material
  • Info & Metrics
  • PDF
Loading

Abstract

OBJECTIVE To investigate the effect of acute hyperglycemia on brain function in adolescents with type 1 diabetes (T1D).

RESEARCH DESIGN AND METHODS Twenty participants with T1D (aged 14.64 ± 1.78 years) and 20 age-matched healthy control subjects (aged 14.40 ± 2.82 years) performed two functional MRI sessions. Participants with T1D performed the first scanning session under euglycemic and the second under hyperglycemic clamp (20 mmol/L [360 mg/dL]).

RESULTS Lower spatial working memory (sWM) capacity during acute hyperglycemia and significant differences in activation of regions of interest during different stages of the sWM task (P = 0.014) were observed.

CONCLUSIONS Acute hyperglycemia negatively affected sWM capacity in adolescents with T1D, which is relevant for daily functioning and academic performance.

Introduction

Type 1 diabetes (T1D) has an impact on the structure and function of the brain in children and adults (1,2). Basic intelligence, psychomotor processing speed, mental flexibility, and attention are noted to be permanently reduced (1,3). Hyperglycemia may have more deleterious effects on the brain than hypoglycemia (1,4).

Spatial working memory (sWM) is decisive in achieving better academic performance (5). We investigated the effects of acute hyperglycemia on sWM in adolescents with T1D.

Research Design and Methods

The primary outcome of this open-label clinical trial (NCT03188757, National Medical Ethics Committee 0120–476/2017/2) was the difference in sWM capacity during acute hyperglycemia compared with euglycemia in adolescents with T1D.

Inclusion criteria were age 11–19 years, duration of T1D 5–10 years, and no severe hypoglycemic episode or diabetic ketoacidosis within the previous year. The control group consisted of age-matched healthy adolescents, not related to participants with T1D.

After an overnight stay to maintain stable glycemia, participants with T1D started with an intravenous euglycemic clamp, during which functional MRI with an sWM task and MRI spectroscopy were performed. Capillary blood glucose concentration was measured (CONTOUR NEXT; Ascensia, Parsippany, NJ) every 15 min and maintained between 5 and 10 mmol/L (90–180 mg/dL). Afterward, the blood glucose level was raised by an intravenous glucose bolus, and a hyperglycemic clamp (6) was maintained between 15 and 25 mmol/L (270–450 mg/dL) for 2 h, during which participants repeated the scanning protocol.

To control for the effects of learning and fatigue, healthy control subjects followed the same experimental protocol, but without any manipulation of glycemia.

Participants were familiarized with the spatial variation of the Sternberg item-recognition task (7) prior to the scanning sessions. Group differences and the effect of induced hyperglycemia on sWM capacity estimates were assessed using a two-way mixed-design ANOVA with within-subject factor session (first vs. second session) and between-subject factor group (participants with T1D vs. healthy control subjects). The analysis was performed using the ez-package (8) separately for sWM loads of two and four items.

Neuroimaging data were acquired with an Achieva 3.0T TX scanner (Philips, Best, the Netherlands). T1- and T2-weighted high-resolution images were acquired, and in each functional session, three T2*-weighted blood oxygen level–dependent images concurrent with sWM task performance, followed by spectroscopy scan using SV-PRESS sequence, were obtained.

Initial image preprocessing followed the Human Connectome Project minimal preprocessing pipeline (9). Further analyses were conducted using FreeSurfer (https://surfer.nmr.mgh.harvard.edu) (10) and in-house code using MATLAB 2014a (https://mathworks.com) and R (11) software packages.

The analysis of functional data was performed on a priori selected regions of interest (ROIs) (frontal eye fields, supplementary motor area, anterior insula, anterior intraparietal area, medial intraparietal area, inferior frontal junction, dorsolateral prefrontal cortex, and medial temporal lobe) (8). The selected ROIs are involved in the spatial information forming and its maintenance and executive control (12,13). Separate estimates of brain activation during encoding, delay, and response phase for each session and sWM load were obtained using a general linear model. Individual activation estimates for each ROI were then submitted to a second-level analysis. The effects of interest on mean ROI responses were investigated using a mixed-effects ANOVA with within-subject factors session (first vs. second), load (2 vs. 4), task phase (encoding, delay, and response), hemisphere (left vs. right), ROI, and a between-subject factor group (participants with T1D vs. healthy control subjects).

In the frontal cortex, ratios of magnetic resonance relaxation–corrected surface areas of N-acetyl aspartate, choline, and creatine were compared within each group and between the groups after functional MRI sessions. The Wilcoxon rank-sum test (between groups) and Wilcoxon signed-rank test (paired difference inside groups between the first and second measurements) were used; correlation between the blood glucose concentration and metabolites was assessed with linear mixed-effects model, all using R.

Results

Twenty adolescents with T1D (mean 14.64 ± 1.78 years of age; 10 female; mean T1D duration 8.00 ± 2.45 years) and 20 healthy age-matched control subjects (mean 14.4 ± 2.82 years of age; 15 female) completed the study protocol. Fifteen adolescents with T1D and 19 control subjects were included in the final analysis (6 were excluded due to motion-related artifacts) (Supplementary Table 1 and CONSORT flow chart in Supplementary Material). The average blood glucose level was 7.6 ± 2.0 mmol/L (137 ± 36 mg/dL) during the euglycemic clamp and 20.1 ± 2.4 mmol/L (362 ± 43 mg/dL) during the hyperglycemic clamp.

Behavioral analysis of the number of retained positions in the sWM task at load four revealed a significant group × session interaction (P = 0.048), reflecting a robust decrease in the estimated number of successfully retained positions in adolescents with T1D versus an increase in healthy control subjects from session 1 to session 2 (Supplementary Fig. 1).

Analysis of brain activation on a priori ROI (Fig. 1A) revealed a significant (P = 0.014) group × session interaction, reflecting a decrease of activation in the second session from overall higher values in adolescents with T1D as compared with only moderate increase in activation in healthy control subjects (Fig. 1B). A significant (P = 0.016) group × session × task phase × side interaction indicated more specific differences in the effect of the session between groups (Fig. 1C). Separate analyses for each combination of task phase (encoding, delay, and response) and hemisphere (left vs. right) revealed significant group × session interaction during response phase in left (P = 0.046) and right (P = 0.016) hemisphere, as shown in the response time course for the two groups averaged across ROIs (Fig. 1D).

Figure 1
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1

Differences in brain activation as assessed by functional MRI during the performance of the sWM task between adolescents with T1D and healthy control subjects. A shows a priori ROIs. B presents the change of activation in ROIs between first and second session in the group with T1D and the healthy control group. C presents change of activation in ROIs between the first and second session in the group with T1D and the healthy control group shown separately for each phase of working memory task and hemisphere. D presents mean time courses of activation in ROIs by group, hemisphere, and session, showing higher levels of activation in participants with T1D during euglycemia and a decrease of activation during hyperglycemia. AI, anterior insula; AIP, anterior intraparietal area; DLPFC, dorsolateral prefrontal cortex; FEF, frontal eye field; IFJ, inferior frontal junction; L, left; MIP, medial intraparietal area; MTL, medial temporal lobe; R, right; SMA, supplementary motor area.

Spectroscopy revealed a significant decrease in of N-acetyl aspartate, choline, and creatine (P < 0.01, P < 0.005, and P < 0.01, respectively) at the end of the hyperglycemic clamp. This decrease correlated significantly (P < 0.01, P < 0.01, and P < 0.05, respectively) with the increase in blood glucose concentrations. The ratios among the metabolites did not change significantly. No significant change in metabolite levels were observed in the control group.

Conclusions

The significantly reduced sWM capacity in adolescents with T1D during acute hyperglycemia observed in our study substantiates previous observations showing a decrease in intelligence quotient scores in children with T1D (4) and impaired WM in adults with T2D, both during acute hyperglycemia (14).

Our study is the first to suggest a direct effect of acute hyperglycemia on sWM. Significantly higher overall brain activation in adolescents with T1D compared with healthy control subjects during the first session reversed to an overall decrease of activation in the second session during hyperglycemia. The increased brain activity during response phase could be a compensatory mechanism for less efficient encoding of stimuli (12). During high sWM load, a failure to engage this compensatory mechanism, observed as a significant drop in activation, could explain the reduced sWM capacity during hyperglycemia.

The overall significant decrease of metabolites in the frontal cortex during hyperglycemia could be related to a concomitant increase in local water content. Hyperglycemia affects the blood-brain barrier and may contribute to clinically silent water content changes in brain regions (15). No changes were observed in the control group.

Our study has limitations: it is single center, included a limited number of participants, and used restricted magnetic resonance acquisitions. The results could be related to other factors than acute hyperglycemia or T1D: changes in the water content or diabetic ketoacidosis at T1D onset (present in 6 out of 20 participants).

sWM enables easily accessible information maintenance over brief time periods and is crucial for goal-directed behavior (12). The impact of acute hyperglycemia on sWM has a direct clinical implication for school performance and other cognitive challenges in this vulnerable population with T1D.

Article Information

Acknowledgments. The authors thank all of the participants with and without diabetes; Simona Klemenčič, clinical psychologist from UMC, Ljubljana, Slovenia, for help with selecting psychometric tasks; Ana Gianini, Jasmina Horvat, Urska Sever, Teja Sever, Tina Robida, Katja Romarić, and Renata Radič-Berglez, all from UMC Ljubljana and University of Ljubljana, Ljubljana, Slovenia, for expert technical assistance; Igor Sersa from Institute Josef Stefan, Ljubljana, Slovenia, for the assistance with data interpretation; and Chris Parkin from CGParkin Communications, Inc., Las Vegas, NV, for language editing.

Funding. This study was supported in part by Javna Agencija za Raziskovalno Dejavnost RS grants P3-0019, P3-0343, J7-9411, and J7-1820 and University Medical Center Ljubljana research grants 20180032 and 20190185.

Funding sources were not involved in the collection, analysis, or interpretation of any data, in the writing of the report, or in the decision to submit the article for publication.

Duality of Interest. G.R. consults for and holds equity in BlackThorn Therapeutics. No other potential conflicts of interest relevant to this article were reported.

Author Contributions. J.Š.O. contributed to conception and design of the study, data acquisition, analysis, and interpretation, and drafting of the manuscript and gave final approval for submission. A.S.O., A.V., D.Š., G.R., and T.B. contributed to conception and design of the study and analysis and interpretation of data, made critical revisions for important intellectual content, and gave final approval for submission. K.D., N.B., and M.A.S. contributed to data acquisition, made critical revisions for important intellectual content, and gave final approval for submission. T.B. is the guarantor of this work and, as such, had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.

Prior Presentation. This study was presented at the 12th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD), Berlin, Germany, 20–23 February 2019.

Footnotes

  • Clinical trial reg. no. NCT03188757, clinicaltrials.gov

  • This article contains supplementary material online at https://doi.org/10.2337/figshare.12152181.

  • Received January 24, 2020.
  • Accepted April 13, 2020.
  • © 2020 by the American Diabetes Association
https://www.diabetesjournals.org/content/license

Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at https://www.diabetesjournals.org/content/license.

References

  1. ↵
    1. Cameron FJ,
    2. Northam EA,
    3. Ryan CM
    . The effect of type 1 diabetes on the developing brain. Lancet Child Adolesc Health 2019;3:427–436
    OpenUrl
  2. ↵
    1. Musen G,
    2. Tinsley LJ,
    3. Marcinkowski KA, et al
    . Cognitive function deficits associated with long-duration type 1 diabetes and vascular complications. Diabetes Care 2018;41:1749–1756
    OpenUrlAbstract/FREE Full Text
  3. ↵
    1. Malone JI
    . Diabetic central neuropathy: CNS damage related to hyperglycemia. Diabetes 2016;65:355–357
    OpenUrlFREE Full Text
  4. ↵
    1. Mauras N,
    2. Mazaika P,
    3. Buckingham B, et al.; Diabetes Research in Children Network (DirecNet)
    . Longitudinal assessment of neuroanatomical and cognitive differences in young children with type 1 diabetes: association with hyperglycemia. Diabetes 2015;64:1770–1779
    OpenUrlAbstract/FREE Full Text
  5. ↵
    1. Mix KS,
    2. Cheng YL
    . The relation between space and math: developmental and educational implications. Adv Child Dev Behav 2012;42:197–243
    OpenUrlCrossRefPubMed
  6. ↵
    1. Ceriello A,
    2. Esposito K,
    3. Ihnat M,
    4. Thorpe J,
    5. Giugliano D
    . Effect of acute hyperglycaemia, long-term glycaemic control and insulin on endothelial dysfunction and inflammation in type 1 diabetic patients with different characteristics. Diabet Med 2010;27:911–917
    OpenUrlPubMed
  7. ↵
    1. Sternberg S
    . Memory-scanning: mental processes revealed by reaction-time experiments. Am Sci 1969;57:421–457
    OpenUrlCrossRefPubMedWeb of Science
  8. ↵
    1. Lawrence M
    . ez: Easy analysis and visualization of factorial experiments. R package version 3.1.2 [Internet], 2011. Available from https://CRAN.R-project.org/package=ez. Accessed 30 December 2016
  9. ↵
    1. Glasser MF,
    2. Coalson TS,
    3. Robinson EC, et al
    . A multi-modal parcellation of human cerebral cortex. Nature 2016;536:171–178
    OpenUrlCrossRefPubMed
  10. ↵
    1. Laboratory for Computational Neuroimaging, Athinoula A. Martinos Center for Biomedical Imaging
    . FreeSurfer, FreeSurfer Software Suite [Internet], 2013. Available from https://surfer.nmr.mgh.harvard.edu/. Accessed 16 March 2019
  11. ↵
    1. R Core Team
    . The R Project for Statistical Computing [Internet], 2014. R Foundation for Statistical Computing, Vienna, Austria. Available from https://www.R-project.org/. Accessed 30 March 2019
  12. ↵
    1. Eriksson J,
    2. Vogel EK,
    3. Lansner A,
    4. Bergström F,
    5. Nyberg L
    . Neurocognitive architecture of working memory. Neuron 2015;88:33–46
    OpenUrlCrossRefPubMed
  13. ↵
    1. Libby LA,
    2. Hannula DE,
    3. Ranganath C
    . Medial temporal lobe coding of item and spatial information during relational binding in working memory. J Neurosci 2014;34:14233–14242
    OpenUrlAbstract/FREE Full Text
  14. ↵
    1. Sommerfield AJ,
    2. Deary IJ,
    3. Frier BM
    . Acute hyperglycemia alters mood state and impairs cognitive performance in people with type 2 diabetes. Diabetes Care 2004;27:2335–2340
    OpenUrlAbstract/FREE Full Text
  15. ↵
    1. Palmer BF,
    2. Clegg DJ
    . Electrolyte and acid-base disturbances in patients with diabetes mellitus. N Engl J Med 2015;373:548–559
    OpenUrlCrossRefPubMed
View Abstract
PreviousNext
Back to top
Diabetes Care: 43 (8)

In this Issue

August 2020, 43(8)
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by Author
  • Masthead (PDF)
Sign up to receive current issue alerts
View Selected Citations (0)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about Diabetes Care.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Acute Hyperglycemia and Spatial Working Memory in Adolescents With Type 1 Diabetes
(Your Name) has forwarded a page to you from Diabetes Care
(Your Name) thought you would like to see this page from the Diabetes Care web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Acute Hyperglycemia and Spatial Working Memory in Adolescents With Type 1 Diabetes
Jasna Šuput Omladič, Anka Slana Ozimič, Andrej Vovk, Dušan Šuput, Grega Repovš, Klemen Dovc, Nataša Bratina, Magdalena Avbelj Stefanija, Tadej Battelino
Diabetes Care Aug 2020, 43 (8) 1941-1944; DOI: 10.2337/dc20-0171

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Add to Selected Citations
Share

Acute Hyperglycemia and Spatial Working Memory in Adolescents With Type 1 Diabetes
Jasna Šuput Omladič, Anka Slana Ozimič, Andrej Vovk, Dušan Šuput, Grega Repovš, Klemen Dovc, Nataša Bratina, Magdalena Avbelj Stefanija, Tadej Battelino
Diabetes Care Aug 2020, 43 (8) 1941-1944; DOI: 10.2337/dc20-0171
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Research Design and Methods
    • Results
    • Conclusions
    • Article Information
    • Footnotes
    • References
  • Figures & Tables
  • Suppl Material
  • Info & Metrics
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • A Meal Detection Algorithm for the Artificial Pancreas: A Randomized Controlled Clinical Trial in Adolescents With Type 1 Diabetes
  • Carbohydrate Requirements for Prolonged, Fasted Exercise With and Without Basal Rate Reductions in Adults With Type 1 Diabetes on Continuous Subcutaneous Insulin Infusion
  • Good Glycemic Outcomes Following Bariatric Surgery Among Patients With Type 2 Diabetes, Obesity, and Low-Titer GAD Antibodies
Show more Novel Communications in Diabetes

Similar Articles

Subjects

  • Pediatrics-Type 1 Diabetes

Navigate

  • Current Issue
  • Standards of Care Guidelines
  • Online Ahead of Print
  • Archives
  • Submit
  • Subscribe
  • Email Alerts
  • RSS Feeds

More Information

  • About the Journal
  • Instructions for Authors
  • Journal Policies
  • Reprints and Permissions
  • Advertising
  • Privacy Policy: ADA Journals
  • Copyright Notice/Public Access Policy
  • Contact Us

Other ADA Resources

  • Diabetes
  • Clinical Diabetes
  • Diabetes Spectrum
  • Scientific Sessions Abstracts
  • Standards of Medical Care in Diabetes
  • BMJ Open - Diabetes Research & Care
  • Professional Books
  • Diabetes Forecast

 

  • DiabetesJournals.org
  • Diabetes Core Update
  • ADA's DiabetesPro
  • ADA Member Directory
  • Diabetes.org

© 2021 by the American Diabetes Association. Diabetes Care Print ISSN: 0149-5992, Online ISSN: 1935-5548.